Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-424047
Filing Date
2013-11-04
Accepted
2013-11-04 06:52:22
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d597048d10q.htm 10-Q 437949
2 EX-31.1 d597048dex311.htm EX-31.1 7378
3 EX-31.2 d597048dex312.htm EX-31.2 7369
4 EX-32.1 d597048dex321.htm EX-32.1 3971
  Complete submission text file 0001193125-13-424047.txt   2981121

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT geva-20130930.xml EX-101.INS 367800
6 XBRL TAXONOMY EXTENSION SCHEMA geva-20130930.xsd EX-101.SCH 35010
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE geva-20130930_cal.xml EX-101.CAL 51652
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE geva-20130930_def.xml EX-101.DEF 74085
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE geva-20130930_lab.xml EX-101.LAB 261070
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE geva-20130930_pre.xml EX-101.PRE 170357
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

EIN.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23155 | Film No.: 131187546
SIC: 2836 Biological Products, (No Diagnostic Substances)